Lupin, a global pharmaceutical company, has achieved a significant milestone in its sustainability journey by earning a double ‘A’ rating from CDP (formerly known as the Carbon Disclosure Project) for its leadership in climate action and water security. This prestigious rating recognizes Lupin’s efforts to reduce its environmental impact and mitigate the risks associated with climate change and water scarcity.<\/p>\n
CDP is a non-profit organization that assesses companies’ environmental performance and transparency. The double ‘A’ rating is the highest rating given by CDP, and it indicates that Lupin has demonstrated exceptional leadership and commitment to environmental stewardship. Lupin is one of only a few companies globally to achieve this rating, and it is a testament to the company’s dedication to sustainability.<\/p>\n
Lupin’s climate action efforts have focused on reducing greenhouse gas emissions, transitioning to renewable energy sources, and implementing energy-efficient technologies. The company has set ambitious targets to reduce its carbon footprint, including a goal to become carbon neutral by 2050. Lupin has also implemented various initiatives to promote sustainable practices throughout its supply chain, including working with suppliers to reduce their environmental impact.<\/p>\n
In addition to its climate action efforts, Lupin has also demonstrated leadership in water security. The company has implemented water conservation measures across its operations, including rainwater harvesting and wastewater treatment. Lupin has also engaged with local communities to promote water conservation and support watershed development projects.<\/p>\n
The double ‘A’ rating from CDP is a significant achievement for Lupin, and it reflects the company’s commitment to sustainability and environmental responsibility. Lupin’s leadership in climate action and water security will not only reduce its environmental impact but also contribute to the well-being of local communities and the planet as a whole. The company’s sustainability efforts are aligned with the United Nations’ Sustainable Development Goals (SDGs), and it is working to integrate the SDGs into its business strategy.<\/p>\n
Overall, Lupin’s double ‘A’ rating from CDP is a testament to the company’s dedication to sustainability and environmental stewardship. The company’s efforts to reduce its environmental impact and promote sustainable practices will have a positive impact on the environment, local communities, and its business operations. As a responsible corporate citizen, Lupin is committed to continuing its sustainability journey and making a positive difference in the world.<\/p>\n","protected":false},"excerpt":{"rendered":"
Lupin, a global pharmaceutical company, has achieved a significant milestone in its sustainability journey by earning a double ‘A’ rating from CDP (formerly known as the Carbon Disclosure Project) for its leadership in climate action and water security. This prestigious rating recognizes Lupin’s efforts to reduce its environmental impact and mitigate the risks associated with […]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","fifu_image_url":"","fifu_image_alt":"","_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[20,2],"tags":[],"class_list":["post-89855","post","type-post","status-publish","format-standard","hentry","category-lupin","category-pharma"],"jetpack_featured_media_url":"","jetpack_sharing_enabled":true,"jetpack-related-posts":[{"id":89848,"url":"https:\/\/smallnews.in\/pharmaceuticals\/2026\/01\/24\/lupin-earns-top-cdp-a-rating-for-efforts-in-combating-climate-change-and-conserving-water\/","url_meta":{"origin":89855,"position":0},"title":"Lupin Earns Top CDP A Rating for Efforts in Combating Climate Change and Conserving Water","author":"Team Small News","date":"January 24, 2026","format":false,"excerpt":"Lupin Limited, a global pharmaceutical major, has achieved a significant milestone in its sustainability efforts by receiving the highest 'A' leadership rating from the Climate Disclosure Project (CDP) for its exceptional performance in Climate Change and Water Security. This recognition is a testament to Lupin's commitment to sustainability and transparency,\u2026","rel":"","context":"In "Lupin"","block_context":{"text":"Lupin","link":"https:\/\/smallnews.in\/pharmaceuticals\/category\/lupin\/"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":89870,"url":"https:\/\/smallnews.in\/pharmaceuticals\/2026\/01\/27\/lupin-achieves-top-esg-rating-from-cdp-for-its-efforts-in-addressing-climate-change-and-water-security\/","url_meta":{"origin":89855,"position":1},"title":"Lupin achieves top ESG rating from CDP for its efforts in addressing climate change and water security.","author":"Team Small News","date":"January 27, 2026","format":false,"excerpt":"Lupin, a global pharmaceutical leader, has been recognized for its exceptional sustainability efforts, receiving the highest \"A\" leadership rating from the Climate Disclosure Project (CDP) for both Climate Change and Water Security. This prestigious recognition solidifies Lupin's position among the world's most sustainable and transparent companies. The double \"A\" rating\u2026","rel":"","context":"In "Lupin"","block_context":{"text":"Lupin","link":"https:\/\/smallnews.in\/pharmaceuticals\/category\/lupin\/"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":89844,"url":"https:\/\/smallnews.in\/pharmaceuticals\/2026\/01\/23\/lupin-achieves-top-esg-score-from-cdp-for-efforts-in-combating-climate-change-and-ensuring-water-security-reported-by-chennai-patrika\/","url_meta":{"origin":89855,"position":2},"title":"Lupin Achieves Top ESG Score from CDP for Efforts in Combating Climate Change and Ensuring Water Security – Reported by Chennai Patrika.","author":"Team Small News","date":"January 23, 2026","format":false,"excerpt":"Lupin Limited, a global pharmaceutical major, has achieved a significant milestone in its sustainability efforts by receiving the highest 'A' leadership rating from the Climate Disclosure Project (CDP) for its exceptional accomplishments in Climate Change and Water Security. This recognition solidifies Lupin's position as a global leader in championing sustainability\u2026","rel":"","context":"In "Lupin"","block_context":{"text":"Lupin","link":"https:\/\/smallnews.in\/pharmaceuticals\/category\/lupin\/"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":89755,"url":"https:\/\/smallnews.in\/pharmaceuticals\/2026\/01\/05\/polypeptide-forms-partnership-with-lupin-speciality-chemicals-magazine\/","url_meta":{"origin":89855,"position":3},"title":"PolyPeptide forms partnership with Lupin | Speciality Chemicals Magazine","author":"Team Small News","date":"January 5, 2026","format":false,"excerpt":"PolyPeptide, a leading manufacturer of peptides, has formed a strategic alliance with Lupin Manufacturing Solutions. The partnership aims to establish a framework for long-term cooperation, focusing on integrated procurement and supply planning for select raw materials. This alliance will enable PolyPeptide to diversify its sourcing options for key materials, including\u2026","rel":"","context":"In "Lupin"","block_context":{"text":"Lupin","link":"https:\/\/smallnews.in\/pharmaceuticals\/category\/lupin\/"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":89790,"url":"https:\/\/smallnews.in\/pharmaceuticals\/2026\/01\/12\/lupin-partners-with-gan-lee-to-bring-fortnightly-glp-1-treatment-to-india-through-exclusive-licensing-deal\/","url_meta":{"origin":89855,"position":4},"title":"Lupin partners with Gan & Lee to bring fortnightly GLP-1 treatment to India through exclusive licensing deal.","author":"Team Small News","date":"January 12, 2026","format":false,"excerpt":"Lupin Limited, a global pharmaceutical company, has entered into an exclusive agreement with Gan&Lee Pharmaceuticals of China to commercialize Bofanglutide, a novel GLP-1 receptor agonist, in India. Bofanglutide is a fortnightly treatment for type 2 diabetes and weight management in overweight and obese adults, offering a reduced injection frequency compared\u2026","rel":"","context":"In "Lupin"","block_context":{"text":"Lupin","link":"https:\/\/smallnews.in\/pharmaceuticals\/category\/lupin\/"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":89792,"url":"https:\/\/smallnews.in\/pharmaceuticals\/2026\/01\/13\/piramal-pharma-enhances-its-global-sustainability-rating-in-recent-corporate-assessment\/","url_meta":{"origin":89855,"position":5},"title":"Piramal Pharma Enhances Its Global Sustainability Rating in Recent Corporate Assessment.","author":"Team Small News","date":"January 13, 2026","format":false,"excerpt":"Piramal Pharma, a leading global pharmaceutical company, has achieved a significant improvement in its score on the Global Corporate Sustainability Assessment (CSA) conducted by S&P Global. The CSA is a widely recognized benchmark for assessing a company's sustainability performance, evaluating factors such as environmental, social, and governance (ESG) practices. In\u2026","rel":"","context":"In "Pharma"","block_context":{"text":"Pharma","link":"https:\/\/smallnews.in\/pharmaceuticals\/category\/pharma\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/smallnews.in\/pharmaceuticals\/wp-content\/uploads\/sites\/6\/2025\/05\/Piramal-Healthcare.jpg?resize=350%2C200&ssl=1","width":350,"height":200},"classes":[]}],"_links":{"self":[{"href":"https:\/\/smallnews.in\/pharmaceuticals\/wp-json\/wp\/v2\/posts\/89855","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/smallnews.in\/pharmaceuticals\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/smallnews.in\/pharmaceuticals\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/smallnews.in\/pharmaceuticals\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/smallnews.in\/pharmaceuticals\/wp-json\/wp\/v2\/comments?post=89855"}],"version-history":[{"count":0,"href":"https:\/\/smallnews.in\/pharmaceuticals\/wp-json\/wp\/v2\/posts\/89855\/revisions"}],"wp:attachment":[{"href":"https:\/\/smallnews.in\/pharmaceuticals\/wp-json\/wp\/v2\/media?parent=89855"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/smallnews.in\/pharmaceuticals\/wp-json\/wp\/v2\/categories?post=89855"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/smallnews.in\/pharmaceuticals\/wp-json\/wp\/v2\/tags?post=89855"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}